FIEBRE MANCHADA Y SU POTENCIAL COINFECCIÓN CON OTRAS ENFERMEDADES TRANSMITIDAS POR VECTOR
DOI:
https://doi.org/10.36790/epistemus.v11i22.40Keywords:
Rickettsia rickettsii, Dengue, Fiebre ChikungunyaAbstract
La fiebre manchada por Rickettsia rickettsii (FMRR) es una enfermedad reemergente transmitida en México por las garrapatas Rhipicephalus sanguineus infectadas por la bacteria homónima. Presentamos 3 casos fatales que cumplieron con criterios de compatibilidad para FMRR, y que al tener un resultado positivo para Dengue o Chikungunya no se solicitó prueba confirmatoria para FMRR o se hizo en días de evolución clínica donde es poco probable encontrar elevación de anticuerpos específicos contra la bacteria. Si bien existe una similitud en el cuadro clínico y de laboratorio entre FMRR y padecimientos febriles exantemáticos endémicos en Sonora, hay datos clínicos, de laboratorio y epidemiológicos que podrían guiar al médico clínico a sospechar de la enfermedad, incluso en presencia de una prueba positiva confirmatoria de algún otro padecimiento. Esta serie de casos es una llamada a estructurar protocolos de estudio en pacientes con enfermedades febriles exantemáticas en regiones endémicas de FMRR como Sonora.
Downloads
References
Dantas-Torres F. Rocky Mountain spotted fever. Lancet Infect Dis 2007; 7(11): 724-32. DOI: https://doi.org/10.1016/S1473-3099(07)70261-X
Chen LF, Sexton DJ. What’s new in Rocky mountain spotted fever? Infect Dis Clin North Am 2008; 22(3): 415-432. DOI: https://doi.org/10.1016/j.idc.2008.03.008
Cunha BA. Clinical features of Rocky Mountain spotted fever. Lancet Infect Dis 2008; 8(3): 143-44. DOI: https://doi.org/10.1016/S1473-3099(08)70022-7
Álvarez-Hernández G, Murillo-Benitez C, Candia-Plata MC, Moro M. Clinical profile and predictors of fatal rocky moun-tain spotted fever in children from Sonora, Mexico. Ped In-fect Dis J 2015; 34(2): 125-30. DOI: https://doi.org/10.1097/INF.0000000000000496
Kirkland JE, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin In-fect Dis 1995; 20(5): 1118-121. DOI: https://doi.org/10.1093/clinids/20.5.1118
Masters E, Olson GS, Weiner SJ, Paddock CD. Rocky mountain spotted fever a clinician’s dilemma. Arch Intern Med 163(7): 769-74. DOI: https://doi.org/10.1001/archinte.163.7.769
Lee N, Lp M, Wong B, Lui G, Yin-Tsang OT, Lai JK, et al. Risk factor associated with life - threatening rickettsial infections. Am J Trop Med Hyg 2008; 78(6): 973-78. DOI: https://doi.org/10.4269/ajtmh.2008.78.973
Zientek J, Dahlgreen FS, McQuiston JH, Regan J. Self-repor-ted treatment practices by healthcare providers could lead to death from Rocky mountain spotted fever. J Pediatr 2014; 164(2): 416-18. DOI: https://doi.org/10.1016/j.jpeds.2013.10.008
Guzmán M and Kouri G. Dengue: an update. Lancet Infect Dis 2002; 2(1): 33-42.Staples. DOI: https://doi.org/10.1016/S1473-3099(01)00171-2
JE, Breiman RF, Powers AM. Chikungunya fever: an epide-miological review of a re-emerging infectious disease. Clin Infect Dis 2009; 49(6): 942-48. DOI: https://doi.org/10.1086/605496
Saswat T, Kumar A, Kumar S, Mamidi P, Muduli S, Kumar N, et al. High rates of co-infection of Dengue and Chikungun-ya virus in Odisha and Maharashtra, India during 2013. Infec Genet Evol 2015; 35: 134-141. DOI: https://doi.org/10.1016/j.meegid.2015.08.006
Walker DH, Hawkins HK, Hudson P. Fulminant Rocky Moun-tain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med 1983; 107 (3): 121-5.
Paddock CD, Greer PW, Ferebee TL, Singleton J, McKechnie DB, Treadwell TA, et al. Hidden mortality attributable to Roc-ky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis 1999; 179 (6): 1469-76. DOI: https://doi.org/10.1086/314776
Abarca K, Oteo JA. Aproximaciones clínicas y principales ric-kettsiosis transmitidas por garrapatas presentes en Latinoa-mérica. Rev Chilena Infectol 2014; 31 (5): 569-76. DOI: https://doi.org/10.4067/S0716-10182014000500009
Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. Chikun-gunya, an epidemic arbovirosis. Lancet Infect Dis 2007; 7: 319-27. DOI: https://doi.org/10.1016/S1473-3099(07)70107-X
Rahman-Malik M, Mnzava A, Mohareb E, Zayed A, Al Kohlani A, Thabet AAK, et al. Chikungunya outbreak in Al-Hudaydah, Yemen, 2011: epidemiological characterization and key les-sons learned for early detection and control. J Epidemiol Glob Health 2014; 4: 203-11. DOI: https://doi.org/10.1016/j.jegh.2014.01.004
Simmons CP, Farrar JJ, Van Vinh Chau N, Wills B. Dengue. N Engl J Med 2012; 366: 1423-32. DOI: https://doi.org/10.1056/NEJMra1110265
Mukkada S, Buckingham SC. Recognition of and prompt treatment for tick-borne infections in children. Infect Dis Clin N Am 2015; 29: 539-555. DOI: https://doi.org/10.1016/j.idc.2015.05.002
De Lara-Huerta J & Cárdenas-Barragán R. Fiebre manchada de las montañas rocosas en pediatría: revisión clínica de una serie de 115 casos. Rev EnfInfecc Ped 2008; 22 (85): 4-9
Torres JR, Codova LG, Castro JS, Rodríguez L, Saravia V, Arve-laez J, et al. Chikungunya fever: atypical and lethal cases in the western hemisphere a Venezuelan experience. ID cases 2 2015: 6-10. DOI: https://doi.org/10.1016/j.idcr.2014.12.002
Delevaux I, Andre M, Colombier M, Albuisson E, Begue RJ, Piette JC, et al. Can procalcitonin measurement help in diffe-rentiating between bacterial infection and other kinds of in-flammatory processes? Ann Rheum Dis 2003; 62(4): 337-40. DOI: https://doi.org/10.1136/ard.62.4.337
Alkholi UM, Al-monem NA, El-Azim AAA, Sultan MH. Serum procalcitonin in viral and bacterial meningitis. J Glob Infect Dis 2011; 3(1): 14-18. DOI: https://doi.org/10.4103/0974-777X.77290
Raczniak GA, Kato C, Chung IH, Austin A, McQuiston JH, Weis E, et al. Case report: co-infection of Rickettsia rickettsii and Streptococcus pyogenes: is fatal Rocky Mountain spotted fe-ver underdiagnosed? Am J Trop Med Hyg 2014; 91(6): 1154-1155. DOI: https://doi.org/10.4269/ajtmh.14-0437
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The magazine acquires the patrimonial rights of the articles only for diffusion without any purpose of profit, without diminishing the own rights of authorship.
The authors are the legitimate owners of the intellectual property rights of their respective articles, and in such quality, by sending their texts they express their desire to collaborate with the Epistemus Magazine, published biannually by the University of Sonora.
Therefore, freely, voluntarily and free of charge, once accepted the article for publication, they give their rights to the University of Sonora for the University of Sonora to edit, publish, distribute and make available through intranets, Internet or CD said work, without any limitation of form or time, as long as it is non-profit and with the express obligation to respect and mention the credit that corresponds to the authors in any use that is made of it.
It is understood that this authorization is not an assignment or transmission of any of your economic rights in favor of the said institution. The University of Sonora guarantees the right to reproduce the contribution by any means in which you are the author, subject to the credit being granted corresponding to the original publication of the contribution in Epistemus.
Unless otherwise indicated, all the contents of the electronic edition are distributed under a license for use and Creative Commons — Attribution-NonCommercial-ShareAlike 4.0 International — (CC BY-NC-SA 4.0) You can consult here the informative version and the legal text of the license. This circumstance must be expressly stated in this way when necessary.
The names and email addresses entered in this journal will be used exclusively for the purposes established in it and will not be provided to third parties or for their use for other purposes.
